Ying Du

Director/Board Member presso Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.

56 anni

Consumer Non-Durables

Health Technology

Profilo

Ying Du is currently a Member-Supervisory Board at Hebei Zhongnuo Pharmaceutical Technology Co., Ltd.
Previously, Ms. Du worked as a Chief Financial Officer & Secretary at CSPC Innovation Pharmaceutical Co., Ltd.

Posizioni attive di Ying Du

Società	Posizione	Inizio
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The private company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million.	Director/Board Member	-

Tutte le posizioni attive di Ying Du

Precedenti posizioni note di Ying Du

Società	Posizione	Fine
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	Director of Finance/CFO	12/04/2023

Vedi nel dettaglio l'esperienza di Ying Du

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ying Du

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	Consumer Non-Durables

Aziende private	1
Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of CSPC Pharmaceutical Group Ltd., Hebei Zhongnuo Pharmaceutical Technology Co., Ltd. manufactures and distributes pharmaceutical products. The private company is based in Shijiazhuang, China. The Chinese company was founded in 2020. Hebei Zhongnuo Pharmaceutical Technology Co. was acquired by CSPC NBP Pharmaceutical Co., Ltd. from CSPC Innovation Pharmaceutical Co., Ltd. on May 08, 2021 for $18.71 million.	Health Technology